Search results
Madrigal Pharmaceuticals Inc (MDGL) Reports Third Quarter 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoMadrigal Pharmaceuticals Inc (NASDAQ:MDGL) reported cash, cash equivalents and marketable securities...
Madrigal Stock Pops As It Makes Inroads Into What Could Be A $160 Billion Market
Investor's Business Daily· 11 months agoMadrigal Pharmaceuticals said Friday it plans to finish submitting its application for approval of a...
Estimating The Fair Value Of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Simply Wall St. via Yahoo Finance· 1 year agoHow far off is Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) from its intrinsic value? Using the most...
Madrigal (MDGL) to Raise Capital Via Public Offering of $500M
Zacks via Yahoo Finance· 8 months agoMadrigal (MDGL) is raising funds through a public offering of 1.25 million shares of its common...
Madrigal (MDGL) Gains on NASH Treatment's Breakthrough Therapy Tag
Zacks via Yahoo Finance· 1 year agoMadrigal Pharmaceuticals' MDGL shares were up almost 13% on Apr 18, as its pipeline candidate,...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 weeks agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript May 7, 2024 Madrigal...
Loss-Making Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Expected To Breakeven In The Medium-Term
Simply Wall St. via Yahoo Finance· 11 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A Breakout
Investor's Business Daily· 1 year agoMadrigal Pharmaceuticals snagged a breakthrough therapy designation for its liver disease treatment...
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
Investor's Business Daily· 8 months agoMadrigal Pharmaceuticals said Wednesday it could win Food and Drug Administration approval for its...
Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis
Benzinga via Yahoo Finance· 2 years agoMadrigal Pharmaceuticals Inc (NASDAQ: MDGL) presented multiple resmetirom abstracts at the European...